Top compounds associated with response to UBE2C


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.04
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.067 0.04
mRNA Elesclomol GDSC1000 pan-cancer AAC 0.066 0.05
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.059 0.05
mRNA Rapamycin gCSI pan-cancer AAC 0.11 0.05
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.061 0.05
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC -0.1 0.05
mRNA NSC-207895 GDSC1000 pan-cancer AAC 0.063 0.05
mRNA PLX4720 CCLE pan-cancer AAC 0.083 0.05
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.05
Download CSV